Paroxetine hydrochloride and Glycolax drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Paroxetine hydrochloride and Glycolax. Common interactions include gastrooesophageal reflux disease among females.

The phase IV clinical study analyzes what interactions people who take Paroxetine hydrochloride and Glycolax have. It is created by eHealthMe based on reports of 12 people who take Paroxetine hydrochloride and Glycolax from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Aug, 05, 2022

12 people who take Paroxetine hydrochloride and Glycolax together, and have interactions are studied.


What is Paroxetine hydrochloride?

Paroxetine hydrochloride has active ingredients of paroxetine hydrochloride. It is often used in depression. eHealthMe is studying from 7,402 Paroxetine hydrochloride users for its effectiveness, alternative drugs and more.

What is Glycolax?

Glycolax has active ingredients of polyethylene glycol 3350. eHealthMe is studying from 1,730 Glycolax users for its effectiveness, alternative drugs and more.

Number of Paroxetine hydrochloride and Glycolax reports submitted per year:

Paroxetine hydrochloride and Glycolax drug interactions.

Common Paroxetine Hydrochloride and Glycolax drug interactions by gender *:

female:

  1. Gastrooesophageal reflux disease
  2. Abdominal pain
  3. Arthritis
  4. Azotaemia
  5. Bacteraemia
  6. Bone density decreased
  7. Bone disorder
  8. Bone erosion
  9. Bone fragmentation
  10. Cardiac failure congestive

male:

n/a

Common Paroxetine Hydrochloride and Glycolax drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Actinomycosis
  2. Angiopathy
  3. Anhedonia
  4. Arthritis
  5. Azotaemia
  6. Bacteraemia
  7. Blood cholesterol increased
  8. Bone density decreased
  9. Bone disorder
  10. Bone erosion

50-59:

  1. Abdominal pain
  2. Abdominal pain upper
  3. Bone disorder
  4. Bone erosion
  5. Bone fragmentation
  6. Cardiac failure congestive
  7. Congestive cardiomyopathy
  8. Constipation
  9. Cough
  10. Deformity

60+:

n/a

Common conditions people have *:

  1. Multiple Myeloma (cancer of the plasma cells): 7 people, 58.33%
  2. High Blood Pressure: 7 people, 58.33%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 58.33%
  4. Fatigue (feeling of tiredness): 7 people, 58.33%
  5. Panic Disorder: 4 people, 33.33%
  6. Ill-Defined Disorder: 4 people, 33.33%
  7. Constipation: 4 people, 33.33%
  8. Headache (pain in head): 2 people, 16.67%
  9. Stress And Anxiety: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Paroxetine hydrochloride and Glycolax?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Paroxetine hydrochloride and Glycolax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Paroxetine hydrochloride interactions:

Browse all interactions between Paroxetine hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Glycolax interactions:

Browse all interactions between Glycolax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on paroxetine hydrochloride and polyethylene glycol 3350 (the active ingredients of Paroxetine hydrochloride and Glycolax, respectively), and Paroxetine hydrochloride and Glycolax (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: